Results 161 to 170 of about 200,328 (301)

Long‐term cost‐effectiveness of belatacept vs. tacrolimus in kidney transplantation: Trade‐off between metabolic benefit and immunological risk

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims This study aimed to evaluate the long‐term cost‐effectiveness of belatacept vs. tacrolimus as maintenance immunosuppression in adult kidney transplant recipients, focusing on the trade‐off between reduced new‐onset diabetes after transplantation (NODAT), immunological risk and potential renal benefit.
Salvatore Di Maria   +2 more
wiley   +1 more source

R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 14

open access: yesJournal of Comparative Effectiveness Research
In this latest update we highlight: a publication from the US FDA regarding the definitions of real-world data (RWD) and real-world evidence (RWE); a publication from academic researchers on a demonstration project for target trial emulation; a ...
Benjamin D Bray, Sreeram V Ramagopalan
doaj   +1 more source

Practice‐level variation in potentially inappropriate prescribing in middle‐aged adults: A repeated cross‐sectional study in South London general practice

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aim To quantify between‐practice variation in potentially inappropriate prescribing (PIP) among middle‐aged adults (45–64 years) in UK general practice, and to identify patient‐ and practice‐level characteristics associated with PIP. Methods Repeated cross‐sectional study using linked data from the Lambeth DataNet and Quality Outcomes Framework across ...
Ryan Jayesinghe   +6 more
wiley   +1 more source

Defining a comprehensive set of value assessment criteria for funders of drug repurposing initiatives

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims This study aims to develop a structured list of value assessment criteria for drug repurposing (DR) projects designed to support consistent, evidence‐informed decision‐making by funders. The assessment criteria were developed within the REMEDi4ALL project, a multi‐stakeholder Horizon Europe funded initiative to advance DR and were validated ...
Dalma Hosszú   +10 more
wiley   +1 more source

Misuse of obesity drugs exposes patients to serious and preventable harms: A French nationwide pharmacovigilance case series

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Introduction The rapid uptake of glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) for obesity has been accompanied by increasing use outside approved indications and medical supervision. Evidence regarding the harms associated with such misuse remains limited because these situations are not captured in clinical trials and are difficult to ...
Jean‐Luc Faillie
wiley   +1 more source

Cell and Gene Therapies Manufacturing Challenges and Integrated Good Manufacturing Practices Solutions: A Lifecycle Perspective

open access: yesBiotechnology and Bioengineering, EarlyView.
Lifecycle perspective on cell and gene therapy manufacturing challenges and enabling GMP solutions. ABSTRACT Cell and gene therapies (CGTs) are revolutionizing modern medicine; however, making these advanced medicines scalable and readily available to commercial manufacturers worldwide is a major challenge. The number of approved CGT products continues
Rajath Samaga   +2 more
wiley   +1 more source

RANCANG BANGUN SISTEM INFORMASI REIMBURSEMENT ELEKTRONIK (E-REIMBURSEMENT) BERBASIS WEB PADA PT VOLTRAS TRAVEL

open access: yes
Sistem reimbursement manual di PT Voltras Travel memiliki berbagai keterbatasan, seperti proses yang memakan waktu, rentan terhadap kesalahan, kurang transparan, dan sulitnya karyawan memantau status pengajuan. Penelitian ini bertujuan untuk merancang
Murti, Aang Wisnu
core   +1 more source

Home - About - Disclaimer - Privacy